Based on recent data, Abbott Laboratories (ABT) shows an Average True Range (ATR) of 2.9 and an Enterprise Value of 192.75B. Its average trading volume over the past 3 months is 8.35M, indicating liquidity. These fundamental metrics provide insight into ABT's underlying financial health and market activity.
| ATR | 2.9 |
| Enterprise Value | 192.75B |
| Avg Vol (3 Months) | 8.35M |
| Avg Vol (10 Days) | 14.05M |
Abbott Laboratories (ABT) technical indicators as of February 6, 2026: the SMA 20 is -5.29%, SMA 50 at -10.21%, and SMA 200 at -15.27%. The RSI 14 value is 31.97, suggesting its current momentum. These technical analysis signals help assess ABT's price trends and potential future movements.
| SMA 20 | -5.29% |
| SMA 50 | -10.21% |
| SMA 200 | -15.27% |
| RSI 14 | 31.97 |
Abbott Laboratories (ABT) stock performance overview as of February 6, 2026: The 52-week high is $141.23 (currently -22.76% below), and the 52-week low is $105.27 (currently 3.62% above). Over the past year, ABT's performance is 6.35%, compared to the S&P 500's 8.96% change.
| 52-Week High | 141.23 |
| 52-Week High Chg | -22.76% |
| 52-Week Low | 105.27 |
| 52-Week Low Chg | +3.62% |
| S&P 500 52-Week Chg | 8.96% |
According to market data, Abbott Laboratories (ABT) stock's recent performance metrics show that over the last month, ABT is -4.4%, with a Year-to-Date (YTD) performance of -3.31%. Over the past year, the stock has seen a 6.35% change. These figures summarize ABT's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 111 | 128.6 | 132.03 | 137.49 | 141.23 | 129.46 |
| Low | 105.68 | 105.27 | 105.27 | 105.27 | 105.27 | 105.27 |
| Performance | -2.81% | -4.40% | -5.76% | -2.64% | +6.35% | -3.31% |
According to current financial data, ABT stock's P/E (TTM) ratio is 29.27, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for ABT, including P/S (4.29), P/B (3.75), and P/FCF (27.50), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ABT | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 29.27 | -1.23 | -26.18 | 32.59 |
| P/S (TTM) | 4.29 | 3.71 | 14.12 | 5.98 |
| P/B (TTM) | 3.75 | 0.22 | -0.58 | 5.45 |
| P/FCF (TTM) | 27.5 | 650.23 | -751.52 | 31.94 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep